Anavex Life Sciences (AVXL) EBIT Growth (1y) (2017 - 2025)
Anavex Life Sciences (AVXL) EBIT Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - | 58.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.34% |
| Sep 30, 2025 | 24.01% |
| Jun 30, 2025 | 0.99% |
| Mar 31, 2025 | 0.88% |
| Dec 31, 2024 | -19.46% |
| Sep 30, 2024 | -12.73% |
| Jun 30, 2024 | -7.92% |
| Mar 31, 2024 | 11.04% |
| Dec 31, 2023 | 26.04% |
| Sep 30, 2023 | 17.18% |
| Jun 30, 2023 | -8.61% |
| Mar 31, 2023 | -23.18% |
| Dec 31, 2022 | -31.22% |
| Sep 30, 2022 | -111.88% |
| Jun 30, 2022 | -106.38% |
| Mar 31, 2022 | -110.05% |
| Dec 31, 2021 | -184.78% |
| Sep 30, 2021 | 1,325.68% |
| Jun 30, 2021 | 1,621.19% |
| Mar 31, 2021 | 4,315.69% |